SNCA / Alpha-Synuclein Antibody (phospho-S129)
Primary AntibodyLSBio Guarantee
| Antibody: | Rabbit Polyclonal |
| Applications: | Enzyme-Linked Immunosorbent Assay, Immunohistochemistry (general), Western Blot |
| Reactivity: | Human, Mouse, Rat |
| Format: | Liquid |
$301.00each
Catalog Number: LS-C380861-50
Catalog Number: LS-C380861
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- Alpha-Synuclein antibody LS-C380861 is an unconjugated rabbit polyclonal antibody to Alpha-Synuclein (SNCA) (pS129) from human. It is reactive with human, mouse and rat. Validated for ELISA, IHC and WB. Cited in 2 publications.
- Application
- ELISA, IHC, WB
- Reactivity
- Hu, Ms, Rt
- Intended Use
- RUO
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Polyclonal Antibodies
- Alternative Names
- Alpha-synuclein | PARK4 | PD1 | SNCA | Synuclein alpha-140 | NACP | PARK1 | aSynuclein | a-Synuclein
- Recommended Dilution: ELISA
- 1:5000
- Recommended Dilution: IHC
- 1:100 - 1:300
- Recommended Dilution: WB
- 1:500 - 1:2000
- UniProt Number
- P37840
- NCBI GenBank
- NM_000345, NP_000336.1
- SwissProt
- P37840
Target
- Target
- Human SNCA / Alpha-Synuclein
- Antigen Species
- Hu
- Epitope
- Phospho-Synuclein-alpha (S129) Polyclonal Antibody detects endogenous levels of Synuclein-alpha protein only when phosphorylated at S129.
- Gene Name
- SNCA
Antibody
- Host Species
- Rb
- Clonality
- Polyclonal
- Isotype
- IgG
Immunogen
- Immunogen
- Synthesized peptide derived from human Synuclein-alpha around the phosphorylation site of S129.
- Immunogen Type
- SP-Lin
Format
- Conjugate/Label
- Unconj
- Format
- Liquid
- Formulation
- PBS, 0.02% Sodium Azide, 50% Glycerol, 0.5% BSA
- Concentration
- 1 mg/mL
- Preservative
- Yes
- Purification Method
- AP
Storage & Handling
- Storage Conditions
- Store at -20°C. Avoid freeze-thaw cycles.
- Recommended Storage Buffer
- PBS
Netrin-1 and its receptor DCC modulate survival and death of dopamine neurons and Parkinson's disease features. Mélissa Jasmin, Eun Hee Ahn, Merja H Voutilainen, Joanna Fombonne, Catherine Guix, Tuulikki Viljakainen, Seong Su Kang, Li-Ying Yu, Mart Saarma, Patrick Mehlen, Keqiang Ye. The EMBO journal. 2021 February;40:e105537. PubMed: 33351190 PMC: PMC7849168